Altaris Capital shells out $1.1B for health imaging maker Analogic

Technology abstract background
Investment firm Altaris Capital Partners is acquiring Analogic, the maker of ultrasound systems, in a deal worth $1.1 billion. (monsitj/ iStock/Getty Images Plus)

Investment firm Altaris Capital Partners is acquiring Analogic, the maker of ultrasound systems, in a deal worth $84 per share, or about $1.1 billion.

The Analogic board approved the deal, which is expected to close by the middle of the year upon approval by shareholders, the company said. When finalized, Analogic will be privately held by Altaris.

The Massachusetts-based company is know for its BK Ultrasound systems used in procedure-driven areas such as urology, surgery and point-of-care. Analogic’s imaging technologies are also used in CT, MRI and digital mammography systems.

FREE DAILY NEWSLETTER

Like this story? Subscribe to FierceBiotech!

Biopharma is a fast-growing world where big ideas come along every day. Our subscribers rely on FierceBiotech as their must-read source for the latest news, analysis and data in the world of biotech and pharma R&D. Sign up today to get biotech news and updates delivered to your inbox and read on the go.

The price for the transaction represents a 25% premium on Analogic’s shares that were selling for $67.45 per share on June 7, 2017, when it reported third-quarter earnings for fiscal 2017 and announced the launch of the strategic review process. The company’s shares had closed the previous day at $74.60 per share.

For the last decade and a half, Altaris has been focused on investments in the medical device, imaging and diagnostics areas.

Suggested Articles

Belgian devicemaker Miracor Medical received a breakthrough designation from the FDA for its treatment designed to limit the damage of a heart attack.

Following an FBI raid and the replacement of its leadership, it’s come to light that the data behind uBiome’s microbiome test may contain flaws.

The National Institutes of Health has tapped the genomics firm Color to help participants understand and act on their results.